Bouchey Financial Group’s AbbVie ABBV Stock Holding History

Bouchey Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$996K	Sell	4,689 -141	-3%	-$31.3K	0.07%	60
2025 Q4	$1.1M	Sell	4,830 -553	-10%	-$126K	0.08%	53
2025 Q3	$1.25M	Buy	5,383 +8	+0.1%	+$1.63K	0.1%	44
2025 Q2	$998K	Buy	5,375 +1,442	+37%	+$268K	0.08%	50
2025 Q1	$824K	Sell	3,933 -70	-2%	-$13.6K	0.07%	51
2024 Q4	$711K	Buy	4,003 +10	+0.3%	+$1.84K	0.06%	57
2024 Q3	$789K	Sell	3,993 -14	-0.3%	-$2.61K	0.07%	57
2024 Q2	$687K	Sell	4,007 -17	-0.4%	-$2.82K	0.07%	56
2024 Q1	$733K	Hold	4,024	–	–	0.07%	53
2023 Q4	$624K	Sell	4,024 -111	-3%	-$16.2K	0.07%	58
2023 Q3	$616K	Buy	4,135 +257	+7%	+$37.7K	0.08%	57
2023 Q2	$522K	Hold	3,878	–	–	0.06%	60
2023 Q1	$618K	Buy	3,878 +325	+9%	+$49.7K	0.08%	49
2022 Q4	$574K	Hold	3,553	–	–	0.08%	49
2022 Q3	$477K	Hold	3,553	–	–	0.07%	52
2022 Q2	$544K	Hold	3,553	–	–	0.09%	47
2022 Q1	$576K	Sell	3,553 -208	-6%	-$30.2K	0.08%	45
2021 Q4	$509K	Buy	3,761 +1,370	+57%	+$162K	0.07%	56
2021 Q3	$258K	Buy	+2,391	New	+$273K	0.04%	79

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bouchey Financial Group's ABBV Position: Q1 2026 in Review

Bouchey Financial Group reduced its AbbVie (ABBV) stake by 2.9% in Q1 2026, selling an estimated $31.3K and leaving 4,689 shares worth $996K. The position accounts for 0.07% of the portfolio, ranked #60.

Bouchey Financial Group first reported a position in ABBV in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.25M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Bouchey Financial Group held 4,689 shares of AbbVie worth $996K as of Q1 2026.
Bouchey Financial Group sold 141 AbbVie shares in Q1 2026, an estimated $31.3K.
AbbVie made up 0.07% of Bouchey Financial Group's portfolio in Q1 2026, its #60 holding.
Bouchey Financial Group first reported a position in AbbVie in Q3 2021 and has held it in 19 quarters since.
Bouchey Financial Group's AbbVie position peaked at $1.25M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bouchey Financial Group's 13F filing for Q1 2026, filed 13 Apr 2026.